# US 2008/0188539 A1 · Ramipril-amino acid salts

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2008/0188539 A1
- Document ID: US20080188539A1
- Status: Published application
- Kind: A1
- Application number: 11/948,057
- Filed: 2007-11-30
- Published: 2008-08-07
- Earliest claimed: 2006-12-01
- Assignees: Selamine Limited
- Inventors: Paul Jonathan Harrison; Anna Marie Elizabeth Power; Deirdre O'Keeffe
- Web page: https://patentgrep.com/patent/US20080188539A1

## CPC

- C07D 209/52: condensed with a ring other than six-membered
- A61P 3/10: for hyperglycaemia, e.g. antidiabetics
- A61P 9/00: Drugs for disorders of the cardiovascular system
- A61P 13/12: of the kidneys
- C07D: HETEROCYCLIC COMPOUNDS (macromolecular compounds C08)
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS

## Abstract

The present invention relates to ramipril-amino acid salts, such as, naturally occurring, basic amino acid salts of ramipril.

## Claims

### Claim 1

A ramipril-amino acid salt.

### Claim 2 (depends on 1)

The salt of claim 1, wherein the amino acid is not arginine or lysine.

### Claim 3 (depends on 1)

The salt of claim 1, wherein the salt is substantially free of ramipril (free acid) and amino acid that is not associated with ramipril (conjugate base).

### Claim 4 (depends on 1)

The salt of claim 1, wherein the amino acid is histidine.

### Claim 5 (depends on 1)

The salt of claim 1, in crystalline form.

### Claim 6 (depends on 1)

The salt of claim 1, in non-crystalline form.

### Claim 7 (depends on 1)

A composition comprising a therapeutically effective amount of the ramipril-amino acid salt of claim 1 and a pharmaceutically acceptable carrier.

### Claim 8 (depends on 7)

The composition of claim 7, further comprising another therapeutic agent.

### Claim 9 (depends on 8)

The composition of claim 8, wherein the other therapeutic is a diuretic, an antiinflammatory agent, an anti-renal failure agent, an anti-diabetic agent, an anti-cardiovascular disease agent, an opioid analgesic agent, a non-opioid analgesic agent, an antibiotic, an antiemetic, an antifungal agent, an antidepressant, an immunomodulatory agent, a cytokine, a hormone, or a β-interferon.

### Claim 10 (depends on 1)

A method for treating a cardiovascular disorder, comprising administering to a subject in need thereof a therapeutically effective amount of the ramipril-amino acid salt of claim 1.

### Claim 11 (depends on 10)

The method of claim 10, further comprising administering another therapeutic agent.

### Claim 12 (depends on 1)

A method for treating an ischemic condition, comprising administering to a subject in need thereof a therapeutically effective amount of the ramipril-amino acid salt of claim 1.

### Claim 13 (depends on 12)

The method of claim 12, further comprising administering another therapeutic agent.

### Claim 14 (depends on 1)

A method for treating renal failure, comprising administering to a subject in need thereof a therapeutically effective amount of the ramipril-amino acid salt of claim 1.

### Claim 15 (depends on 14)

The method of claim 14, further comprising administering another therapeutic agent.

### Claim 16 (depends on 1)

A method for treating diabetes mellitus or a diabetic condition comprising administering to a subject in need thereof a therapeutically effective amount of the ramipril-amino acid salt of claim 1.

### Claim 17 (depends on 16)

The method of claim 16, further comprising administering another therapeutic agent.

### Claim 18 (depends on 1)

A method for reducing the incidence of recurrence or severity of a symptom of a cardiovascular disorder, an ischemic condition, renal failure, diabetes mellitus or a diabetic condition, comprising administering to a subject in need thereof a therapeutically effective amount of the ramipril-amino acid salt of claim 1.

### Claim 19 (depends on 18)

The method of claim 18, further comprising administering another therapeutic agent.
